ascopubs.org

A phase II prospective study about the efficacy and toxicity of the locally advanced NPC patients treated with CCRT followed with metronomic chemotherapy.

Toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin ineligible head and neck cancer patients. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...
ascopubs.org

Updates on Treatments and Management of Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype is strongly associated with Epstein-Barr virus (EBV) infection, whereas emerging data suggest that a subset ...
EurekAlert!

Landmark study uncovers role of tumor microenvironment in nasopharyngeal carcinoma progression which supports personalized treatment

Molecular profiling of over 1,000 nasopharyngeal cancer (NPC) patients’ tumours reveals distinct differences in tumour microenvironment of locoregionally advanced NPC, supporting the use of ...
News Medical

Radiomics significantly outperforms clinical models for predicting NPC treatment outcome

Nasopharyngeal carcinoma (NPC) is a highly aggressive malignancy, with most patients presenting at locally advanced stages. While immune checkpoint inhibitors, such as PD-1 blockade, have reshaped ...